Results

Total Results: 257 records

Showing results for "screening for suicide risk".

  1. effectivehealthcare-admin.ahrq.gov/products/form/child-growth-development-outcomes
    November 01, 2024 - Vision, Hearing, and Developmental Screening and Followup Research Protocol December 2, … Vision, Hearing, and Developmental Screening and Followup Research Protocol August 2, 2024 … Research Protocol December 22, 2023 The Effect of Dietary Digestible Carbohydrate Intake on Risk … Research Protocol December 21, 2023 The Effect of Dietary Digestible Carbohydrate Intake on RiskScreening and Followup SEAD Portal Dec 02, 2024 SEAD Submission Form for Medical
  2. effectivehealthcare-admin.ahrq.gov/products/antipsychotics-children/research-protocol
    December 01, 2019 - perspective Timing: See KQ1 above Settings: See KQ1 above Question 4: Do the effectiveness and risks … be rated as high risk of bias. … The overall risk of bias will be considered low only if all components are rated as having a low risk … The risk of bias for all other studies will be rated as unclear. … Data Synthesis For each study, we will analyze comparisons between dichotomous outcomes using risk
  3. effectivehealthcare-admin.ahrq.gov/products/allocation-scarce-resources/protocol
    April 01, 2020 - Actions taken in advance to prepare for large-scale public health (e.g., stockpiling). … rather than performed in duplicate as for the original report. … Risk of bias (quality) assessment: We will use five critical appraisal criteria consistent with the … Vision, Hearing, and Developmental Screening and Followup Research Protocol May 02, 2024 … Effective Health Care Program, Agency for Healthcare Research and Quality, Rockville, MD.
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/opioid-treatments-chronic-pain-protocol.pdf
    December 19, 2018 - addressed the risks and benefits of opioids for chronic pain, dosing strategies, and risk assessment … long-term opioid therapy only when benefits are likely to exceed risks; use risk mitigation strategies … strategies, including (1) opioid management plans, (2) patient education, (3) urine drug screening, … mitigation strategies, including (1) opioid management plans, (2) patient education, (3) urine drug screening … The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a
  5. effectivehealthcare-admin.ahrq.gov/products/mental-illness-heart/research-protocol
    December 01, 2019 - shortened life expectancies relative to the general population to an extent that is not explained by suicide … Individuals who are taking antipsychotics and consequently at risk for elevated lipid levels … or Individuals who are taking antipsychotics and consequently at risk for elevated lipid levels … Articles included by either reviewer will undergo full-text screening. … At the full-text screening stage, two independent reviewers must agree on a final inclusion/exclusion
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/depression-treatment-ssri_research-protocol.pdf
    June 15, 2010 - Harms associated with any of these interventions are evaluated in KQ2 and can include suicide, sexual … We have selected the Newcastle Ottawa Quality Assessment Tool13 to assess risk of bias for observational … Studies that pass the first screening for fatal flaws will be classified into high or low risk of bias … and Laird random-effects model to generate pooled measures of treatment effect (i.e., estimates of relativeScreening for child and adolescent depression in primary care settings: a systematic evidence review
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-3.xlsx
    September 30, 2015 - body mass index; CI = confidence interval; COWS = Clinical Opiate Withdrawal Score; DAST = Drug Abuse Screening … care provider; RCT = randomized controlled trial; RMDQ = Roland Morris Disability Questionnaire; RR = relative … CI 2.05 to 2.96, p<0.001 Anxiety: 505/22097 vs. 6174/152194; aIRR 1.79, 95% CI 1.48 to 2.15, p<0.001 Suicide … D Any opioid-related event: 5.3% vs. 6.1% vs. 3.4% vs. 3.6%, p<0.0001 Suicide (fatal or nonfatal): 1.0% … of suicide: aHR 3.63 (95% CI 1.42 to 9.25) vs. aHR 4.47 (95% CI 1.68 to 11.88) vs. aHR 1.29 (95% CI
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_executive.pdf
    January 27, 2012 - or who prefer disulfiram and understand the relative risks of taking the drug; and (3) to have specialist … the risk of bias for each study. … between acamprosate and naltrexone, whereas the risks of headache and vomiting were higher for those … Behavioral counseling after screening for alcohol misuse in primary care: a systematic review and … Screening, Behavioral Counseling, and Referral in Primary Care To Reduce Alcohol Misuse.
  9. effectivehealthcare-admin.ahrq.gov/products/form/measurement-criteria-qdr/draft-comments
    December 01, 2024 - Vision, Hearing, and Developmental Screening and Followup Research Protocol August 2, 2024 … Multiple Cancer Screening: A Systematic Review Research Protocol June 26, 2024 Mindfulness-Based … Research Protocol December 22, 2023 The Effect of Dietary Digestible Carbohydrate Intake on Risk … Research Protocol December 21, 2023 The Effect of Dietary Digestible Carbohydrate Intake on Risk … Cardiovascular Disease Research Protocol December 8, 2023 Implementation of Recommended Screening
  10. #05 DEPRESSION (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - In these cases, patients are exposed to prolonged and increased risk of suicide and death. … mixed clinical trial results, as well as safety risks of using a controlled substance … treating depressed patients at high risk of suicide are also registered.36,37 Manufacturer and regulatory … , as well as the risk of anticholinergic effects noted for scopolamine’s approved indications. … for suicide.
  11. effectivehealthcare-admin.ahrq.gov/products/mhs4-opioid-stewardship/protocol
    September 01, 2023 - Studies of Effectiveness Literature Searches for Studies of Effectiveness Data Extraction Risk … However, opioids also carry well known risks, including for overdose, misuse, and opioid use disorder … the risk of bias of randomized controlled trials (RCTs) or the ROBINS-I tool for assessing the Risk … The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. … ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs4-opioid-stewardship-protocol.pdf
    July 01, 2023 - However, opioids also carry well known risks, including for overdose, misuse, and opioid use disorder … Risk of Bias (Quality) Assessment For studies that address Review Question 5 about the effectiveness … of PSPs, the primary reviewer will use the Cochrane Collaboration’s tool for assessing the risk of … The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. … ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
  13. effectivehealthcare-admin.ahrq.gov/products/cad-women-treatment/research
    December 01, 2019 - States, treatment studies to date have primarily enrolled men and may not reflect the benefits and risks … of effectiveness in women due to demographic factors (≥65 or ≥80 years of age) or clinical factors (risk … factors that may modify clinical effectiveness--so that firmer conclusions can be reached about the risk … Research Protocol Dec 22, 2023 The Effect of Dietary Digestible Carbohydrate Intake on Risk … Cardiovascular Disease Research Protocol Dec 08, 2023 Implementation of Recommended Screening
  14. effectivehealthcare-admin.ahrq.gov/products/gout/research
    March 01, 2020 - Review methods We used standard systematic review methods including duplicate screening and data extraction … High-strength evidence supports the finding that ULT does not reduce the risk of acute gout attacks within … However, moderate-strength evidence supports a role for ULT in reducing the risk of acute gout attacks … Low-strength evidence supports treating to a specific target serum urate level to reduce the risk of … supports the finding that prophylactic therapy with low-dose colchicine or low dose NSAIDs reduces the risk
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mental-illness-outcomes_disposition-comments.pdf
    January 15, 2015 - risk population at risk for medical problems. … However, the epidemiological characteristics and risk factors for suicide are very different from those … Clinicians can sometimes identify modifiable risks for suicide, with the presumption that intervention … can reduce suicide risk. … (One might argue that more frequent screenings for cardiovascular or diabetic risk may be needed but
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ptsd-5-protocol-update-2023.pdf
    January 01, 2023 - of bias using the Cochrane risk-of-bias tool for randomized trials (RoB 2),16 and calculating standardized … Assessment of Methodological Risk of Bias of Individual Studies: The EPC will conduct a risk of bias … RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. … Results for suicide- or self-directed violence-related outcomes 2. … RoB 2, A REVISED TOOL FOR ASSESSING RISK OF BIAS IN RANDOMISED TRIALS: ASSESSMENT ELEMENTS 1.1) Was
  17. effectivehealthcare-admin.ahrq.gov/products/form/menopausal-symptoms
    February 01, 2025 - Vision, Hearing, and Developmental Screening and Followup Research Protocol August 2, 2024 … Multiple Cancer Screening: A Systematic Review Research Protocol June 26, 2024 Mindfulness-Based … Research Protocol December 22, 2023 The Effect of Dietary Digestible Carbohydrate Intake on Risk … Research Protocol December 21, 2023 The Effect of Dietary Digestible Carbohydrate Intake on Risk … Cardiovascular Disease Research Protocol December 8, 2023 Implementation of Recommended Screening
  18. effectivehealthcare-admin.ahrq.gov/products/antipsychotics-children-update/research-protocol
    April 01, 2020 - Lastly, differences in some harms outcomes (e.g., weight gain and metabolic risks) have been shown to … ideations or behaviors, or death by suicide* Long-term (≥ 6 month followup) school performance and … We will track the screening and selection results in EndNote. C. … The risk of bias for all other studies will be rated as medium. … For binary outcomes, we will use a relative risk (RR) of 0.75 and 1.25 to represent clinically important
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - The risk of being seizure free for either 6–12 or 24 months was significantly lower for newer antiepileptic … , HLA-B 1502 genotyping could be used as a screening tool and use of tegretol should be avoided. … Suicidal risk and suicide attempts in people treated with antiepileptic drugs for epilepsy. … , suicide attempts Antiepileptic drugs probably do not have an impact on suicidality Misra, 201219 … The risk of being seizure free for either 6–12 or 24 months was significantly lower for newer antiepileptic
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - The risk of being seizure free for either 6–12 or 24 months was significantly lower for newer antiepileptic … , HLA-B 1502 genotyping could be used as a screening tool and use of tegretol should be avoided. … Suicidal risk and suicide attempts in people treated with antiepileptic drugs for epilepsy. … , suicide attempts Antiepileptic drugs probably do not have an impact on suicidality Misra, 201219 … The risk of being seizure free for either 6–12 or 24 months was significantly lower for newer antiepileptic

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: